Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization

Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization

Abstract Background New-onset atrial fibrillation (NOAF) is a common complication in patients with acute myocardial infarction (AMI) during hospitalization. Galectin-3 (Gal-3) is a novel inflammation marker that is significantly associated with AF. The association between post-AMI NOAF and Gal-3 dur...

Full description

Bibliographic Details
Main Authors: Qianhui Wang, Wei Huai, Xiaoguang Ye, Yuxia Pan, Xinchun Yang, Mulei Chen, Qing-Bian Ma, Yuanfeng Gao, Yuan Zhang
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Cardiovascular Disorders
Subjects:
Galectin-3
Acute myocardial infarction
New-onset atrial fibrillation
Biomarker
Online Access:https://doi.org/10.1186/s12872-022-02827-y

Internet

https://doi.org/10.1186/s12872-022-02827-y

Similar Items